Nuvasive reported $234.58M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Abiomed ABMD:US $ 241.88M 66.43M
Atricure ATRC:US $ 119.75M 52.13M
Baxter International BAX:US $ 3258M 122M
Becton, Dickinson and BDX:US $ 2283M 870M
Cardiovascular Systems CSII:US $ 66.86M 4.21M
Cooper Companies COO:US $ 95.9M 16.3M
Dexcom DXCM:US $ 1444.3M 285.5M
Edwards Lifesciences EW:US $ 1506.9M 194.1M
Globus Medical GMED:US $ 361.88M 93.09M
Haemonetics HAE:US $ 192.42M 18.96M
Hill Rom HRC:US $ 271.8M 0.7M
Hologic HOLX:US $ 1170.3M 342.7M
Inogen INGN:US $ 241.58M 2.73M
Insulet PODD:US $ 630.1M 17.2M
Integra Lifesciences IART:US $ 470.23M 72.82M
Intuitive Surgical ISRG:US $ 8219.7M 7321.8M
Medtronic MDT:US $ 2900M 104M
Merit Medical Systems MMSI:US $ 68.9M 0.77M
Nuvasive NUVA:US $ 234.58M 30.44M
Orthofix International OFIX:US $ 82.71M 2.74M
Stryker SYK:US $ 2563M 322M
Tandem Diabetes Care TNDM:US $ 112.38M 13.8M
Teleflex TFX:US $ 481.17M 119.39M
Zimmer Biomet Holdings Inc ZBH:US $ 919.6M 122.8M